Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in Gastroenterology

Retrieve available abstracts of 109 articles:
HTML format
Text format



Single Articles


    March 2019
  1. SINGAL AG, Lim JK, Kanwal F
    AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2019 Mar 13. pii: S0016-5085(19)33558.
    PubMed     Text format    


  2. HAMDANE N, Juhling F, Crouchet E, El Saghire H, et al
    HCV-induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
    Gastroenterology. 2019 Mar 2. pii: S0016-5085(19)32506.
    PubMed     Text format     Abstract available


    February 2019
  3. TORRES HA, Pundhir P, Mallet V
    Hepatitis C virus infection in patients with cancer: impact on clinical trial enrollment, selection of therapy, and prognosis.
    Gastroenterology. 2019 Feb 21. pii: S0016-5085(19)30435.
    PubMed     Text format    


  4. CACOUB P
    Hepatitis C Virus Infection, a New Modifiable Cardiovascular Risk Factor.
    Gastroenterology. 2019 Feb 15. pii: S0016-5085(19)30382.
    PubMed     Text format    


  5. KARIMZADEH H, Kiraithe MM, Oberhardt V, Alizei ES, et al
    Mutations in Hepatitis D Virus Allow it to Escape Detection by CD8+ T Cells and Evolve at the Population Level.
    Gastroenterology. 2019 Feb 12. pii: S0016-5085(19)30366.
    PubMed     Text format     Abstract available


  6. ANDERSON RT, Lim SG, Mishra P, Josephson F, et al
    Challenges, Considerations, and Principles to Guide Trials of Combination Therapies for Chronic Hepatitis B Virus.
    Gastroenterology. 2019;156:529-533.
    PubMed     Text format    


  7. YEO YH, Ho HJ, Yang HI, Tseng TC, et al
    Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.
    Gastroenterology. 2019;156:635-646.
    PubMed     Text format     Abstract available


    January 2019
  8. KEFALAKES H, Koh C, Sidney J, Amanakis G, et al
    Hepatitis D Virus-specific CD8(+) T Cells Have a Memory-like Phenotype Associated With Viral Immune Escape in Patients With Chronic Hepatitis D Virus Infection.
    Gastroenterology. 2019 Jan 18. pii: S0016-5085(19)30095.
    PubMed     Text format     Abstract available


  9. DUSHEIKO G, Wang B
    Hepatitis B Surface Antigen Loss: Too Little, Too Late and the Challenge for the Future.
    Gastroenterology. 2019 Jan 11. pii: S0016-5085(19)30036.
    PubMed     Text format    


  10. SALEM G, Adhikari LJ
    Hepatitis C, and Cannot See!
    Gastroenterology. 2019 Jan 2. pii: S0016-5085(18)35432.
    PubMed     Text format    


  11. LEE BP, Im GY, Lucey MR, Terrault NA, et al
    Reply.
    Gastroenterology. 2019;156:286-287.
    PubMed     Text format    


  12. COFFIN CS, Zhou K, Terrault NA
    New and Old Biomarkers for Diagnosis and Management of Chronic Hepatitis B Virus Infection.
    Gastroenterology. 2019;156:355-368.
    PubMed     Text format     Abstract available


  13. GEHRING AJ, Protzer U
    Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection.
    Gastroenterology. 2019;156:325-337.
    PubMed     Text format     Abstract available


  14. MCNAUGHTON AL, D'Arienzo V, Ansari MA, Lumley SF, et al
    Insights From Deep Sequencing of the HBV Genome-Unique, Tiny, and Misunderstood.
    Gastroenterology. 2019;156:384-399.
    PubMed     Text format     Abstract available


  15. XIA Y, Liang TJ
    Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection.
    Gastroenterology. 2019;156:311-324.
    PubMed     Text format     Abstract available


    December 2018
  16. VERGARA C, Thio CL, Johnson E, Kral AH, et al
    Multi-Ancestry Genome-Wide Association Study of Spontaneous Clearance of Hepatitis C Virus.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35421.
    PubMed     Text format     Abstract available


  17. LIANG TJ, Terrault N
    Viral Hepatitis and Hepatocellular Carcinoma.
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35423.
    PubMed     Text format    


  18. ALTER HJ, Chisari FV
    Is Elimination of Hepatitis B and C a Pipe Dream or Reality?
    Gastroenterology. 2018 Dec 26. pii: S0016-5085(18)35422.
    PubMed     Text format    


    November 2018
  19. BUTT AA, Yan P, Shuaib A, Abou-Samra AB, et al
    Direct-acting Antiviral Therapy for HCV Infection is Associated with a Reduced Risk of Cardiovascular Disease Events.
    Gastroenterology. 2018 Nov 13. pii: S0016-5085(18)35264.
    PubMed     Text format     Abstract available


  20. WARD JW, Hinman AR
    What is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
    Gastroenterology. 2018 Nov 1. pii: S0016-5085(18)35205.
    PubMed     Text format     Abstract available


  21. NAGAI S, Chau LC, Schilke RE, Safwan M, et al
    Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Gastroenterology. 2018;155:1451-1462.
    PubMed     Text format     Abstract available


    October 2018
  22. IOANNOU GN, Feld JJ
    What are the Benefits of a Sustained Virologic Response to Direct-acting Antiviral Therapy for HCV Infection?
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35166.
    PubMed     Text format     Abstract available


  23. KULIK L, El-Serag HB
    Epidemiology and Management of Hepatocellular Carcinoma.
    Gastroenterology. 2018 Oct 24. pii: S0016-5085(18)35165.
    PubMed     Text format     Abstract available


  24. KOH C, Heller T, Glenn JS
    Pathogenesis of and New Therapies for Hepatitis D.
    Gastroenterology. 2018 Oct 18. pii: S0016-5085(18)35162.
    PubMed     Text format     Abstract available


  25. BAUMERT TF, Berg T, Lim JK, Nelson DR, et al
    Status of Direct-acting Antiviral Therapy for HCV Infection and Remaining Challenges.
    Gastroenterology. 2018 Oct 17. pii: S0016-5085(18)35155.
    PubMed     Text format     Abstract available


  26. DELTENRE P, Marot A, Moreno C
    Outcomes after early liver transplantation for patients with severe alcoholic hepatitis: Additional evidence from a meta-analysis.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35151.
    PubMed     Text format    


  27. VISENTINI M, Fiorilli M, Casato M
    Persistence of pathogenic B cell clones and relapse of cryoglobulinemic vasculitis in HCV-cured patients.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35150.
    PubMed     Text format    


  28. SOLGA SF, Goldberg DS, Spacek LA, Forde KA, et al
    Comment on B Lee et al Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018 Oct 10. pii: S0016-5085(18)35153.
    PubMed     Text format    


  29. O'BRIEN TR, Yang HI, Groover S, Jeng WJ, et al
    Genetic Factors That Affect Spontaneous Clearance of Hepatitis C or B Virus, Response to Treatment, and Disease Progression.
    Gastroenterology. 2018 Oct 1. pii: S0016-5085(18)35083.
    PubMed     Text format     Abstract available


  30. KIM D, Li AA, Gadiparthi C, Khan MA, et al
    Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.
    Gastroenterology. 2018;155:1154-1163.
    PubMed     Text format     Abstract available


  31. PERRY I, Patel D
    Hemoptysis: Call the Gastroenterologist?
    Gastroenterology. 2018;155:e1-e2.
    PubMed     Text format    


    September 2018
  32. BAILEY JR, Barnes E, Cox AL
    Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.
    Gastroenterology. 2018 Sep 26. pii: S0016-5085(18)35035.
    PubMed     Text format     Abstract available


  33. REHERMANN B, Thimme R
    Insights From Antiviral Therapy into Immune Responses to HBV and HCV Infection.
    Gastroenterology. 2018 Sep 26. pii: S0016-5085(18)35037.
    PubMed     Text format     Abstract available


  34. HU J, Lin YY, Chen PJ, Watashi K, et al
    Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development.
    Gastroenterology. 2018 Sep 19. pii: S0016-5085(18)35030.
    PubMed     Text format     Abstract available


  35. VYAS AK, Jindal A, Trehanpati N
    Ponder the Innate Immunity in Hepatitis B Infection.
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34759.
    PubMed     Text format    


  36. LUO X, Li H, Ma L, Zhou J, et al
    Expression of STING Is Increased in Liver Tissues from Patients With NAFLD and Promotes Macrophage-mediated Hepatic Inflammation and Fibrosis in Mice.
    Gastroenterology. 2018 Sep 10. pii: S0016-5085(18)34959.
    PubMed     Text format     Abstract available


  37. JACOBSON IM
    Re: Sofosbuvir, Velpatasvir, and Ribavirin in HCV.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34936.
    PubMed     Text format    


  38. PRABHU A, Chapman TP, Cobbold JFL
    A Rare Cause of Hepatitis.
    Gastroenterology. 2018 Sep 7. pii: S0016-5085(18)34944.
    PubMed     Text format    


  39. BASSEGODA O, Sole C, Diaz A
    An unusual cause of acute severe hepatitis.
    Gastroenterology. 2018 Sep 7. pii: S0016-5085(18)34945.
    PubMed     Text format    


    August 2018
  40. BOYER A, Park SB, de Boer Y, Li Q, et al
    TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes.
    Gastroenterology. 2018 Aug 22. pii: S0016-5085(18)34892.
    PubMed     Text format     Abstract available


  41. OJHA RP, MacDonald BR, Chu TC, Marcus JL, et al
    Potential Overestimation of Racial Disparities in Response to the 8-Week Ledipasvir/Sofosbuvir Regimen for Hepatitis C Virus Genotype 1 Infection.
    Gastroenterology. 2018 Aug 14. pii: S0016-5085(18)34876.
    PubMed     Text format    


    July 2018
  42. LUNEMANN S, Schobel A, Kah J, Fittje P, et al
    Interactions Between KIR3DS1 and HLA-F Activate Natural Killer Cells to Control HCV Replication in Cell Culture.
    Gastroenterology. 2018 Jul 19. pii: S0016-5085(18)34785.
    PubMed     Text format     Abstract available


  43. NAHON P, Layese R, Bourcier V, Cagnot C, et al
    Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
    Gastroenterology. 2018 Jul 18. pii: S0016-5085(18)34781.
    PubMed     Text format     Abstract available


  44. KOH S, Kah J, Tham CYL, Yang N, et al
    Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3.
    Gastroenterology. 2018;155:180-193.
    PubMed     Text format     Abstract available


    June 2018
  45. ESTEBAN R, Pineda JA, Calleja JL, Casado M, et al
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology. 2018 Jun 26. pii: S0016-5085(18)34684.
    PubMed     Text format     Abstract available


    May 2018
  46. LIAW YF, Jeng WJ, Ming-Ling
    Quantitative HBsAg Kinetics in Retreatment Decision for Off-therapy Hepatitis B Flare in HBeAg-Negative Patients.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30409.
    PubMed     Text format    


  47. GARDINI AC, Conti F, Brillanti S, Andreone P, et al
    Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals.
    Gastroenterology. 2018 May 7. pii: S0016-5085(18)30419.
    PubMed     Text format    


  48. LOUVET A, Thursz MR, Kim DJ, Labreuche J, et al
    Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data.
    Gastroenterology. 2018 May 5. pii: S0016-5085(18)34495.
    PubMed     Text format     Abstract available


  49. MOORMAN AC, Xing J, Nelson NP
    Need for Increasing Hepatitis A Virus Vaccination Among Patients Infected With Hepatitis B Virus and Hepatitis C Virus.
    Gastroenterology. 2018 May 3. pii: S0016-5085(18)34481.
    PubMed     Text format    


    April 2018
  50. BONACCI M, Lens S, Marino Z, Londono MC, et al
    Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
    Gastroenterology. 2018 Apr 26. pii: S0016-5085(18)30485.
    PubMed     Text format     Abstract available


  51. CAO P, Yang A, Wang R, Xia X, et al
    Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Gastroenterology. 2018 Apr 24. pii: S0016-5085(18)30481.
    PubMed     Text format     Abstract available


  52. LEE BP, Mehta N, Platt L, Gurakar A, et al
    Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30442.
    PubMed     Text format     Abstract available


  53. CALVARUSO V, Cabibbo G, Cacciola I, Petta S, et al
    Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents.
    Gastroenterology. 2018 Apr 12. pii: S0016-5085(18)30441.
    PubMed     Text format     Abstract available


  54. MORSE A, Barritt AS 4th, Jhaveri R
    Individual State Hepatitis C Data Supports Expanding Screening Beyond Baby Boomers to All Adults.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30304.
    PubMed     Text format    


  55. SCOTT RA, Aithal GP, Francis ST, Irving WL, et al
    Pretreatment Lesions on Magnetic Resonance Imaging in Patients With Hepatitis C Virus Infection Diagnosed With Hepatocellular Carcinoma After Initiating Direct-Acting Antiviral Therapy.
    Gastroenterology. 2018 Apr 2. pii: S0016-5085(18)30305.
    PubMed     Text format    


    March 2018
  56. WANG X, Dong Q, Li Q, Li Y, et al
    Dysregulated Response of Follicular Helper T cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.
    Gastroenterology. 2018 Mar 12. pii: S0016-5085(18)30313.
    PubMed     Text format     Abstract available


  57. GRUNVOGEL O, Colasanti O, Lee JY, Kloss V, et al
    Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll Like Receptor 3 in Hepatocytes.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30309.
    PubMed     Text format     Abstract available


  58. EL-SHERIF O, Jiang ZG, Tapper EB, Huang KC, et al
    Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection.
    Gastroenterology. 2018 Mar 10. pii: S0016-5085(18)30314.
    PubMed     Text format     Abstract available


  59. PONZETTO A, Figura N
    Risk of Hepatocellular Carcinoma After Cure of Hepatitis C Virus.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30153.
    PubMed     Text format    


  60. LO GH
    The Elevation of Hepatic Venous Pressure Gradient After Sustained Virologic Response in Hepatitis C Virus-Related Cirrhosis.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30148.
    PubMed     Text format    


  61. MANDORFER M, Reiberger T, Peck-Radosavljevic M
    Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response.
    Gastroenterology. 2018 Mar 8. pii: S0016-5085(18)30150.
    PubMed     Text format    


    February 2018
  62. PHAM LV, Ramirez S, Gottwein JM, Fahnoe U, et al
    HCV Genotype 6a Escape from and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30212.
    PubMed     Text format     Abstract available


  63. TEDESCO D, Thapa M, Chin CY, Ge Y, et al
    Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic gammadelta T-cell Receptor-positive Cells and Pathogenesis of Cholestatic Liver Disease.
    Gastroenterology. 2018 Feb 15. pii: S0016-5085(18)30214.
    PubMed     Text format     Abstract available


  64. WANG Y, Chen G, Pan Q, Zhao J, et al
    Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient.
    Gastroenterology. 2018 Feb 9. pii: S0016-5085(18)30017.
    PubMed     Text format    


  65. BOETTLER T, Thimme R
    Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection.
    Gastroenterology. 2018 Feb 7. pii: S0016-5085(18)30159.
    PubMed     Text format    


  66. MA AT, Feld JJ
    Hepatitis B Reactivation With Hepatitis C Treatment: Bringing Some Clarity to the Black Box.
    Gastroenterology. 2018 Feb 6. pii: S0016-5085(18)30161.
    PubMed     Text format    


  67. SUSLOV A, Boldanova T, Wang X, Wieland S, et al
    Hepatitis B Virus Does Not Interfere with Innate Immune Responses in the Human Liver.
    Gastroenterology. 2018 Feb 2. pii: S0016-5085(18)30078.
    PubMed     Text format     Abstract available


  68. TAVIS JE, Lomonosova E
    NVR 3-778 Plus Pegylated Interferon-alpha Treatment for Chronic Hepatitis B Viral Infections: Could 1 + 1 = 3?
    Gastroenterology. 2018;154:481-482.
    PubMed     Text format    


  69. KLUMPP K, Shimada T, Allweiss L, Volz T, et al
    Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
    Gastroenterology. 2018;154:652-662.
    PubMed     Text format     Abstract available


    January 2018
  70. MUTZ P, Metz P, Lempp FA, Bender S, et al
    HBV Bypasses the Innate Immune Response and Does not Protect HCV From Antiviral Activity of Interferon.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30112.
    PubMed     Text format     Abstract available


  71. AGHEMO A, Colombo M
    Glecaprevir/Pibrentasvir: The Final Piece in the Hepatitis C Virus Treatment Puzzle?
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30100.
    PubMed     Text format    


  72. YOSHIKAWA T, Ohana M, Fukuda A
    High fever after radiofrequency ablation of hepatocellular carcinoma.
    Gastroenterology. 2018 Jan 31. pii: S0016-5085(18)30134.
    PubMed     Text format    


  73. BONI C, Vecchi A, Rossi M, Laccabue D, et al
    TLR7 Agonist Increases Responses Of HBV-Specific T Cells And Natural Killer Cells In Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
    Gastroenterology. 2018 Jan 26. pii: S0016-5085(18)30072.
    PubMed     Text format     Abstract available


  74. MOORMAN AC, Xing J, Rupp LB, Gordon SC, et al
    Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C-Infected Patients in the United States.
    Gastroenterology. 2018 Jan 19. pii: S0016-5085(17)36689.
    PubMed     Text format    


    December 2017
  75. POURCET B, Zecchin M, Ferri L, Beauchamp J, et al
    Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity Of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36725.
    PubMed     Text format     Abstract available


  76. WU X, Dao Thi VL, Liu P, Takacs CN, et al
    Pan-Genotype Hepatitis E Virus Replication in Stem Cell-derived Hepatocellular Systems.
    Gastroenterology. 2017 Dec 22. pii: S0016-5085(17)36303.
    PubMed     Text format     Abstract available


  77. GOTTWEIN JM, Pham LV, Mikkelsen LS, Ghanem L, et al
    Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape Variants.
    Gastroenterology. 2017 Dec 21. pii: S0016-5085(17)36720.
    PubMed     Text format     Abstract available


  78. CHOI YS, Jung MK, Lee J, Choi SJ, et al
    Tumor Necrosis Factor-producing T-regulatory Cells are Associated With Severe Liver Injury in Patients With Acute Hepatitis A.
    Gastroenterology. 2017 Dec 8. pii: S0016-5085(17)36685.
    PubMed     Text format     Abstract available


  79. DUSSEAUX M, Masse-Ranson G, Darche S, Ahodantin J, et al
    Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.
    Gastroenterology. 2017;153:1647-1661.
    PubMed     Text format     Abstract available


    November 2017
  80. LIU CJ, Chuang WL, Sheen IS, Wang HY, et al
    Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36369.
    PubMed     Text format     Abstract available


  81. DEBING Y, Schmid MA, Neyts J
    New Models to Study Hepatitis E Virus Replication and Particular Characteristics of Infection: The Needle Hides in the Hay Stack.
    Gastroenterology. 2017 Nov 21. pii: S0016-5085(17)36372.
    PubMed     Text format    


  82. TREPO E, Goossens N, Fujiwara N, Song WM, et al
    Combination of Gene Expression Signature and Model for End-stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
    Gastroenterology. 2017 Nov 17. pii: S0016-5085(17)36367.
    PubMed     Text format     Abstract available


  83. SHERMAN KE, Shah VH
    Viral Hepatitis: Knowledge and Treatments for HBV/HCV and Associated Transplantation and Neoplasia.
    Gastroenterology. 2017 Nov 14. pii: S0016-5085(17)36348.
    PubMed     Text format    


  84. DIETZ J, Susser S, Vermehren J, Peiffer KH, et al
    Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 13. pii: S0016-5085(17)36353.
    PubMed     Text format     Abstract available


  85. DEBES JD, van Tilborg M, Groothuismink ZMA, Hansen BE, et al
    Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-acting Antivirals.
    Gastroenterology. 2017 Nov 1. pii: S0016-5085(17)36295.
    PubMed     Text format     Abstract available


    October 2017
  86. RATTAY T, Dumont P, Heinzow HS, Hutton DW, et al
    Cost-effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers.
    Gastroenterology. 2017 Oct 23. pii: S0016-5085(17)36275.
    PubMed     Text format     Abstract available


  87. JOHN M, Metwally M, Mangia A, Romero-Gomez M, et al
    TLL1 rs17047200 Increases the Risk of Fibrosis Progression in Caucasian Patients With Chronic Hepatitis C.
    Gastroenterology. 2017 Oct 6. pii: S0016-5085(17)36134.
    PubMed     Text format    


  88. MONDELLI MU
    Liver MAIT Cells in Hepatitis C: Pathogenetic Role or Innocent Bystanders?
    Gastroenterology. 2017 Oct 4. pii: S0016-5085(17)36186.
    PubMed     Text format    


    September 2017
  89. MONTPELLIER C, Wychowski C, Sayed IM, Meunier JC, et al
    Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein.
    Gastroenterology. 2017 Sep 25. pii: S0016-5085(17)36179.
    PubMed     Text format     Abstract available


  90. CHILDS-KEAN LM, Hong J
    Detectable Viremia at the End of Treatment With Direct-Acting Antivirals Can Be Associated With Subsequent Clinical Cure in Patients With Chronic Hepatitis C: A Case Series.
    Gastroenterology. 2017 Sep 4. pii: S0016-5085(17)35912.
    PubMed     Text format    


    August 2017
  91. MAAN R, Feld JJ
    Risk for hepatocellular carcinoma after HCV antiviral therapy with direct-acting antivirals: case closed?
    Gastroenterology. 2017 Aug 31. pii: S0016-5085(17)36085.
    PubMed     Text format    


  92. YU ML
    Resistance-Associated Substitutions in Short Duration of Interferon-Free Direct-Acting Antivirals for Hepatitis C.
    Gastroenterology. 2017 Aug 3. pii: S0016-5085(17)35886.
    PubMed     Text format    


  93. BOLTE FJ, O'Keefe AC, Webb LM, Serti E, et al
    Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.
    Gastroenterology. 2017 Aug 2. pii: S0016-5085(17)35975.
    PubMed     Text format     Abstract available


    July 2017
  94. MISHRA P, Florian J, Peter J, Vainorius M, et al
    Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
    Gastroenterology. 2017 Jul 27. pii: S0016-5085(17)35956.
    PubMed     Text format    


  95. LENS S, Alvarado E, Marino Z, Londono MC, et al
    Effects of All-oral Anti-viral Therapy on HVPG and Systemic Hemodynamics in Patients with Hepatitis C Virus-associated Cirrhosis.
    Gastroenterology. 2017 Jul 19. pii: S0016-5085(17)35922.
    PubMed     Text format     Abstract available


  96. YU MW, Lin CL, Liu CJ, Yang SH, et al
    Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35866.
    PubMed     Text format     Abstract available


    June 2017
  97. KANWAL F, Kramer J, Asch SM, Chayanupatkul M, et al
    Risk of Hepatocellular Cancer in HCV Patients Treated with Direct Acting Antiviral Agents.
    Gastroenterology. 2017 Jun 19. pii: S0016-5085(17)35797.
    PubMed     Text format     Abstract available


  98. ENOMOTO M, Murakami Y, Kawada N
    Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35638.
    PubMed     Text format    


  99. DE MARCO L, Pellicano R
    When to Search for Occult Infection After Eradication of Hepatitis C?
    Gastroenterology. 2017 Jun 2. pii: S0016-5085(17)35601.
    PubMed     Text format    


    May 2017
  100. KANWAL F, Bacon BR, Beste LA, Brill JV, et al
    Hepatitis C Virus Infection Care Pathway-A Report From the American Gastroenterological Association Institute HCV Care Pathway Work Group.
    Gastroenterology. 2017;152:1588-1598.
    PubMed     Text format    


  101. SINGH S, Muir AJ, Dieterich DT, Falck-Ytter YT, et al
    American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases.
    Gastroenterology. 2017;152:1544-1577.
    PubMed     Text format     Abstract available


    April 2017
  102. LAIDLAW SM, Marukian S, Gilmore RH, Cashman SB, et al
    Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent from Interferons.
    Gastroenterology. 2017 Apr 26. pii: S0016-5085(17)35530.
    PubMed     Text format     Abstract available


  103. JACOBSON IM, Lawitz E, Gane EJ, Willems BE, et al
    Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir In Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
    Gastroenterology. 2017 Apr 5. pii: S0016-5085(17)35399.
    PubMed     Text format     Abstract available


    March 2017
  104. JACOBSON IM, Lim JK, Fried MW
    AGA Institute Clinical Practice Update: Care of Patients Who Have Achieved a Sustained Virologic Response (SVR) Following Antiviral Therapy for Chronic Hepatitis C Infection.
    Gastroenterology. 2017 Mar 23. pii: S0016-5085(17)30327.
    PubMed     Text format     Abstract available


  105. MISHRA P, Chen M
    Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?
    Gastroenterology. 2017 Mar 18. pii: S0016-5085(17)30295.
    PubMed     Text format    


    January 2017
  106. BESSE-PATIN A, Leveille M, Oropeza D, Nguyen BN, et al
    Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-gamma Coactivator 1alpha to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
    Gastroenterology. 2017;152:243-256.
    PubMed     Text format     Abstract available


    November 2016
  107. LI F, Kaffenberger B, Hart PA
    An Unusual Rash During Evaluation for Chronic Pancreatitis.
    Gastroenterology. 2016 Nov 25. pii: S0016-5085(16)34961.
    PubMed     Text format    


    April 2016
  108. KOK KS, Wharton R, Rushbrook SM
    An Unexpected Cause of Pancreatitis.
    Gastroenterology. 2016 Apr 30. pii: S0016-5085(16)00172.
    PubMed     Text format    


  109. BARRESI L, Ligresti D, Traina M
    A Challenging Diagnosis for a Biliary Stricture.
    Gastroenterology. 2016 Apr 29. pii: S0016-5085(16)00215.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: